Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Stem Cell Isolation
PROCEDURE
3 trials
Sponsors
Al-Azhar University
, SWOG Cancer Research Network
, National Cancer Institute (NCI)
Conditions
AL Amyloidosis
Fecal Incontinence
Plasma Cell Leukemia
Phase 1
Stem Cells Therapy for Fecal Incontinence in Children After Posterior Sagittal Ano-rectoplasty
NCT02161003
Al-Azhar University
Fecal Incontinence
Start: 2013-10-31
End: 2016-12-31
Target: 50
Updated: 2014-06-11
Phase 2
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Not yet recruiting
NCT07605416
National Cancer Institute (NCI)
Plasma Cell Leukemia
Start: 2026-07-29
End: 2032-11-06
Target: 74
Updated: 2026-07-06
Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Recruiting
NCT06022939
SWOG Cancer Research Network
AL Amyloidosis
Start: 2024-07-01
End: 2030-10-29
Target: 338
Updated: 2026-05-06
Related Papers
A Phase III, Randomized Study of Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone (DARA-VCD) Induction Followed By Autologous Stem Cell Transplant or Dara-VCD Consolidation and Daratumumab Maintenance in Patients with Newly Diagnosed AL Amyloidosis
Blood
2024-11-05
A phase III, randomized study of daratumumab, cyclophosphamide, bortezomib and dexamethasone (DARA-VCD) induction followed by autologous stem cell transplant or DARA-VCD consolidation and daratumumab maintenance in patients with newly diagnosed AL amyloidosis.
Journal of Clinical Oncology
2024-06-01